Bio-Reference Laboratories Inc., Dianon deal

DIAN rejected BRLI's previously announced unsolicited bid, stating it was financially inadequate and not a good strategic fit for DIAN (see BioCentury Sept. 5). BRLI (Elwood Park, N.J.) proposed to purchase DIAN in a stock swap in which DIAN shareholders would receive one BRLI share plus $1 for each DIAN share held. ...